Why is U.S. Physical Therapy, Inc. ?
- ROCE(HY) Highest at 7.02%
- DIVIDEND PER SHARE(HY) Highest at USD 8.6
- NET SALES(Q) Highest at USD 197.34 MM
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -23.82%, its profits have fallen by -15.9%
- Along with generating -23.82% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to U.S. Physical Therapy, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is U.S. Physical Therapy, Inc. for you?
Medium Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 7.02%
Highest at USD 8.6
Highest at USD 197.34 MM
Highest at 1,263.17
Fallen by -2.79% (YoY
Higher at USD 23.98 MM
Highest at 8.6 times
Highest at USD 30.59 MM
Highest at 15.5 %
Highest at USD 22.59 MM
Highest at 54.18 %
Highest at USD 2.42 MM
Here's what is working for U.S. Physical Therapy, Inc.
Net Profit (USD MM)
Net Sales (USD MM)
Operating Profit to Interest
DPS (USD)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Debtors Turnover Ratio
Net Profit (USD MM)
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for U.S. Physical Therapy, Inc.
Debt-Equity Ratio
Interest Paid (USD MM)






